Sign in

    Anshi • Jefferies

    Anshi Thakur is an analyst whose recent professional roles include work at Jefferies Financial Group Inc. and previous experience with M Science, demonstrating a background in financial analysis and data-driven research. While at Jefferies, Anshi contributed to in-depth sector research and provided analytical support on companies tracked within the firm's coverage universe. Her career trajectory reflects a transition from specialized research roles at M Science into broader equity analysis at Jefferies, emphasizing rigorous methodology and sector expertise. She also holds professional credentials requisite for analyst positions, although specific FINRA registrations or securities licenses are not directly available.

    Anshi's questions to Verastem Inc (VSTM) leadership

    Anshi's questions to Verastem Inc (VSTM) leadership • Q2 2025

    Question

    Anshi, on behalf of Kelly Hsu, asked about the key performance indicators Verastem is tracking to measure the launch success of AvmapKefaxin and how those metrics might indicate momentum for the second half of the year.

    Answer

    President and CEO Dan Paterson explained that it's early in the launch, but the company is tracking data from specialty pharmacies and distributors. COO Matthew Ros elaborated that performance reporting will be anchored against three strategic imperatives: engagement with the healthcare community, ensuring seamless patient access, and supporting the patient population.

    Ask Fintool Equity Research AI